Register of Autoimmune Bullous Dermatoses (REGIBUL)

CHU de Reims

Status: Completed

Conditions: Autoimmune Bullous Dermatoses

Treatments: Other: Data collection

Study type: Observational

Funder types: Other

Identifiers

NCT02899923

PO16091

Details and patient eligibility

About

Autoimmune bullous dermatoses are a group of diseases with chronic course. They are provoked by the production of autoantibodies against the dermal-epidermal junction or against the inter-keratinocyte junctions, resulting in the formation of intra-epidermal or sub-epidermal blisters.

The diagnosis of autoimmune bullous dermatoses is based on clinical and immunopathological findings, including skin direct immunofluorescence.

Systemic corticosteroid therapy is generally considered as the mainstay of treatment for many years both for bullous pemphigoid and pemphigus which are the most frequent diseases.

Full description

The aim of the study is the creation of a register of patients suffering from autoimmune bullous dermatoses to quickly identify patients who can be included in clinical trials or retrospective epidemiological studies

Enrollment: 750 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with autoimmune bullous dermatosis
• patients cared for in dermatology referral center of Reims, Rouen or Limoges
• patient consenting to participate to the study

Exclusion criteria

• patient <18 years

Trial design

750 participants in 1 patient group

Autoimmune bullous dermatoses

Description:

Patients with autoimmune bullous dermatoses

Treatment:

Other: Data collection